<--- Back to Details
First PageDocument Content
Influenza / Influenza vaccine / PubMed / FluMist / Vaccination schedule / Flu pandemic / Vaccination / Multifactor dimensionality reduction / Medicine / Health / Vaccines
Date: 2010-08-25 07:32:21
Influenza
Influenza vaccine
PubMed
FluMist
Vaccination schedule
Flu pandemic
Vaccination
Multifactor dimensionality reduction
Medicine
Health
Vaccines

1: Abramson ZH, Avni O, Levi O, Miskin IN

Add to Reading List

Source URL: vaers.hhs.gov

Download Document from Source Website

File Size: 168,80 KB

Share Document on Facebook

Similar Documents

179  CANCER CLASSIFICATION USING SINGLE GENES XIAOSHENG WANG1 OSAMU GOTOH1,2

179 CANCER CLASSIFICATION USING SINGLE GENES XIAOSHENG WANG1 OSAMU GOTOH1,2

DocID: 1pDk4 - View Document

Vaccine Safety Bibliography AprilRetracted: Immunological properties reveal the monovalent and bivalent recombinant dengue virus-like particles as candidate vaccine for dengue. Microbiol ImmunolMar; 59(3)

Vaccine Safety Bibliography AprilRetracted: Immunological properties reveal the monovalent and bivalent recombinant dengue virus-like particles as candidate vaccine for dengue. Microbiol ImmunolMar; 59(3)

DocID: 1ah2x - View Document

Vaccine Safety Bibliography MarchErratum: Early cervical myelitis after human papilloma virus vaccination. Neurol Neuroimmunol NeuroinflammJan 14;2(1):e64. eCollection 2015 Feb. Link to PubMed abstract: h

Vaccine Safety Bibliography MarchErratum: Early cervical myelitis after human papilloma virus vaccination. Neurol Neuroimmunol NeuroinflammJan 14;2(1):e64. eCollection 2015 Feb. Link to PubMed abstract: h

DocID: 189rs - View Document

Vaccine Safety Bibliography FebruaryErratum: Early cervical myelitis after human papilloma virus vaccination. Neurol Neuroimmunol NeuroinflammJan 14; 2(1):e64. Link to PubMed abstract: http://www.ncbi.nlm

Vaccine Safety Bibliography FebruaryErratum: Early cervical myelitis after human papilloma virus vaccination. Neurol Neuroimmunol NeuroinflammJan 14; 2(1):e64. Link to PubMed abstract: http://www.ncbi.nlm

DocID: 17KsL - View Document

Vaccine Safety Bibliography AprilRetracted: Immunological properties reveal the monovalent and bivalent recombinant dengue virus-like particles as candidate vaccine for dengue. Microbiol ImmunolMar; 59(3)

Vaccine Safety Bibliography AprilRetracted: Immunological properties reveal the monovalent and bivalent recombinant dengue virus-like particles as candidate vaccine for dengue. Microbiol ImmunolMar; 59(3)

DocID: 17xSp - View Document